MYH7 and neoplasm: This finding implies that PD-1+ cells, potentially representing activated T cells, become more abundant in the lymph nodes following tumor-induced activation, and this increase is further enhanced by anti-mPD-1 therapy (Fig. 4D), which appears necessary for increased infiltration of activated T cells into the tumor microenvironment (Fig. 2B).